Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: A prospective study

Retina

Volumn 23, Issue 4, 2003, Pages 486-490

  Bashshur, Ziad F ^a   Taher, Ali ^a   Masri, Abdul Fattah ^a   Najjar, Danny ^a   Arayssi, Thurayya K ^a   Noureddin, Baha' N ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; RISK FACTOR;

EID: 0041335446     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200308000-00007     Document Type: Article

References (37)

1. Gupta A, Agarwal A, Bansal RK, Agarwal A. Ischaemic central retinal vein occlusion in the young. Eye 1993;7:138-142.
2. Weinberg DV. Venous occlusive disease of the retina. In: Albert DM, Jakobiec FA, Azar DT, et al, eds. Principles and practice of ophthalmology, 2nd ed. Philadelphia: WB Saunders, 2000:1887-1900.
3. Clarkson JC. Central retinal vein occlusion. In: Ryan SJ, Schachat AP, Murphy RB, eds. Retina, 2nd ed. St. Louis: Mosby-Year Book, 1994:1379-1385.
4. Hayreh SS, Zimmerman MB, Podhajsky BSN. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429-441.
5. Backhouse O, Parapia L, Mahomed I, Lee D. Familial thrombophilia and retinal vein occlusion. Eye 2000;14(pt 1):13-17.
6. Dori D, Beiran I, Gelfand Y, et al. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. Am J Ophthalmol 2000;129(1):106-108.
7. Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 1999;77(6):634-637.
8. Abu El-Asrar Am, Abdel Gader AG, Al-Amro S, Al-Momen AK. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998;95(2):133-243.
9. Glueck CJ, Bell H, Vadlamani L, et al. Heritable thrombophilia and fibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999;117(1):43-49.
10. Asherson RA, Harris EN. Anticardiolipin antibodies: clinical associations. Post Grad Med J 1986;48:1081-1087.
11. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies, lupus anticoagulant and anticardiolipin antibodies. Arch Neurol 1987;44:876-883.
12. Godeau P, Bietry O'Piette JC, Wechsler B. Anticoagulants circulants: les conditions cliniques du diagnostic. Rev Med Interne 1985;6:523-541.
13. Hughes GRV, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489.
14. Rum PJA, Lang B, Engler H, Peter HH. Primary antiphospholipid syndrome (PAPS): two case reports and therapeutic implications. Rheumatol Int 1991;10:255-260.
15. Asherson RA, Khamashta MA, Ordis-Ros J, et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-374.
16. Lockshin MD. Antiphospholipid antibody syndrome. In: Ruddy S, Harris ED, Sledge CB, eds. Kelley's textbook of rheumatology, 6th ed. Philadelphia: WB Saunders, 2001:1145-1152.
17. Glacet-Bernard A, Bayani N, Chretien P, Cochard C, LeLong F, Coscas G. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol 1994;112:790-795.
18. Acheson JF, Gregson RM, Schulenburg WE. Vaso-occlusive retinopathy in the primary antiphospholipid syndrome. Eye 1991;5:48-55.
19. Snyers B, Lambert M, Hardy JP. Retinal and choroidal vasoocclusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 1990;10:255-260.
20. Watts MT, Greaves M, Haardy JP. Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy. Eye 1991;5:75-79.
21. Levine SR, Crofts JW, Lesser GR, Floberg J, Welch KMA. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 1988;95:686-692.
22. Garcia-Vicente C, Belmonte J, Ramirez J, Castellano J. Retinopatia proliferante y anticoagulante lupico. Arch Soc Esp Oftalmol 1988;55:387-392.
23. Pulido JS, Ward LM, Fisman GA, Goodwin JA, Froelich CJ, Sanghvi JP. Anti phospholipid antibodies associated with retinal vascular disease. Retina 1987;7:215-218.
24. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989;96:896-904.
25. Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128(6):725-732.
26. Kalogeropoulos CD, Spyrou P, Stefaniotou MI, Tsironi EE, Drosos AA, Psilas KG. Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol 1998;95(2):109-120.
27. Wiechens B, Schroder JO, Potzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997;123(6):848-850.
28. Dori D, Gelfand YA, Brenner B, Miller B. Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. Retina 1997;17:555-557.
29. Dunn JP, Noorily SW, Petri M, Finkelstein D, Rosenbaum JT, Jabs DA. Antiphospholipid antibodies and retinal vascular disease. Lupus 1996;5(4):313-322.
30. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R, Mariani G. Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions. Thromb Res 1996;83(2):183-188.
31. Abu el-Asrar Am, al-Momen AK, al-Amro S, Abdel Gader AG, Tabbara KF. Prothrombotic states associated with retinal venous occlusion in young adults. Int Ophthalmol 1996-1997;20:197-204.
32. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and antiphospholipid specificity. Ann Rheum Dis 1987;46:1-6.
33. Dostal C, Paleckova A, Novak M, Jahn M, Dostal C. [Why are there anti-cardiolipin antibodies in patients with infectious mononucleosis and in patients with systemic lupus erythematosus?] Vnitr Lek 1990;36(11):1050-1056.
34. Santiago MB, Cossermelli W, Tuma MF, Pinto MN, Oliveira RM. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 1989;8:23-28.
35. Mengarelli A, Minotti C, Palumbo G, et al. High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogenic stem cell transplantation. Br J Haematol 2000;108:126-131.
36. Levy RA, Gharavi AE, Sammaritano LR, et al. Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. J Rheumatol 1990;17:1036.
37. Scott JA, Arnold JJ, Currie JM, et al. No excess of factor V: QS06 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients. Ophthalmologica 2001;215(3): 217-221.